• Botulinum Toxin Assay (CDC)
  • Septin 9 (SEPT9) Gene Mutation Analysis
  • CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • Oxcarbazepine, Urine
  • Fatty Acid Profile, Peroxisomal
  • Babesia microti Antibody, IgG, IFA
  • Glucose-6-Phosphate Dehydrogenase (G6PD)
  • HLA-B27 Genotyping for Uveitis
  • Bromazepam
  • Mycoplasma pneumoniae, Culture
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

References
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.
Loading...